293 Effect of high dose cholecalciferol during sle flares in mir-146a expression, regulatory t-cells and il-17a expression
| Autor: | António Marinho, B. Martins da Silva, Daniela Boleixa, C Vasconcelos, C. Carvalho, Andreia Bettencourt |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
medicine.medical_specialty
Innate immune system business.industry Peripheral blood mononuclear cell Negative regulator chemistry.chemical_compound Endocrinology chemistry Internal medicine Concomitant Therapy Gene expression Immunology microRNA medicine Vitamin D and neurology skin and connective tissue diseases Cholecalciferol business |
| Zdroj: | Poster Session. |
| Popis: | Background and aims A few microRNAs have known gene expression regulatory roles in innate immunity. The miR-146a, seems to be a negative regulator of innate immunity. Interestingly, miR-146a has been reported to be downregulated in PBMCs of SLE patients, being negatively correlated with clinical disease activity and with IFN levels. The ability of vitamin D to regulate miRs and their emerging relationship have been proposed through several experimental approaches. The aim of this study was to determine the Vitamin D effect in miR-146a expression and in T-Reg and TCD4 + IL-17A producing cells, in SLE. Methods An interventional study with 3 weeks follow-up of SLE patients with a high dose vitamin D supplementation (50.000 UI or 100.000 UI/Week) was done. We assessed four female patients who had a SLEDAI >6 and at least one BILAG A. At screening, relevant data were compiled: SLEDAI-2K, BILAG score, concomitant therapy, previous SLE manifestations, 25(OH)D levels, T-Reg/IL-17A ratio and miR-146a expression. At Week 3: 25(OH) D levels, T-Reg/IL-17A + ratio, miR-146a expression, SLEDAI 2 K, BILAG and concomitant therapy. Results No significant difference were found, regarding Vitamin D levels, before and after supplementation. Regarding Tregs/IL-17A ratio before and after supplementation, no benefits, regarding enhancing of T-regs or decrease of Il 17-A producing cells. No significative differences were found in miR-146a expression between controls and SLE active patients before and after vitamin D supplementation. Conclusions Severe SLE activity may cause resistance to Vitamin D therapeutical effects, including enhancing of Vitamin D levels and immunogenetic effects. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|